<!DOCTYPE html>
<html>
  <script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-79742963-1', 'auto');
  ga('send', 'pageview');

</script>

  <!-- Begin Jekyll SEO tag v2.5.0 -->
<title>What’s new for ‘angiotensin AND cancer’ in PubMed - coffee, statins, ACE inhibitors and more! | Ciência médica</title>
<meta name="generator" content="Jekyll v3.7.4" />
<meta property="og:title" content="What’s new for ‘angiotensin AND cancer’ in PubMed - coffee, statins, ACE inhibitors and more!" />
<meta name="author" content="Francisco H C Felix" />
<meta property="og:locale" content="en" />
<meta name="description" content="This message contains My NCBI what’s new results from the National Center for BiotechnologySender’s message: Sent on Saturday, 2011 Oct 08Search angiotensin cancer &lt;div&gt;&lt;div&gt;&lt;table bgcolor=&quot;#CCCCCC&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot;&gt;PubMed Results&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;Items 1 - 4&lt;/div&gt;&lt;div&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;1.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Tanaka N, Miyajima A, Kosaka T, Miyazaki Y, Shirotake S, Shirakawa H, Kikuchi E, Oya M.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.399. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21970881 [PubMed - as supplied by publisher]How angiotensin II type 1 receptor blockers can overcome platinum resistance in cancer cells.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;2.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Statin prescriptions and breast cancer recurrence risk: a danish nationwide prospective cohort study.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. Epub 2011 Aug 2.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21813413 [PubMed - in process]Simvastatin users had less breast cancer recurrence - a Harvard Medical School Study&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;3.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Yoon C, Yang HS, Jeon I, Chang Y, Park SM.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;CMAJ. 2011 Oct 4;183(14):E1073-84. Epub 2011 Aug 29.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21876027 [PubMed - in process] Free Article Last word on ACE inhibitors/AT1R blockers and cancer: they can be protective, after all! &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;4.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;High Molecular Weight Coffee Melanoidins are Inhibitors for Matrix Metalloproteases.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Demarco LM, Fischer S, Henle T.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Agric Food Chem. 2011 Oct 1. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21961901 [PubMed - as supplied by publisher]Coffee, sir?  Melanoidins from coffee - a new group of MMP inhibitors that can play a pivotal role in cancer treatment.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;" />
<meta property="og:description" content="This message contains My NCBI what’s new results from the National Center for BiotechnologySender’s message: Sent on Saturday, 2011 Oct 08Search angiotensin cancer &lt;div&gt;&lt;div&gt;&lt;table bgcolor=&quot;#CCCCCC&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot;&gt;PubMed Results&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;Items 1 - 4&lt;/div&gt;&lt;div&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;1.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Tanaka N, Miyajima A, Kosaka T, Miyazaki Y, Shirotake S, Shirakawa H, Kikuchi E, Oya M.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.399. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21970881 [PubMed - as supplied by publisher]How angiotensin II type 1 receptor blockers can overcome platinum resistance in cancer cells.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;2.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Statin prescriptions and breast cancer recurrence risk: a danish nationwide prospective cohort study.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. Epub 2011 Aug 2.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21813413 [PubMed - in process]Simvastatin users had less breast cancer recurrence - a Harvard Medical School Study&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;3.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Yoon C, Yang HS, Jeon I, Chang Y, Park SM.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;CMAJ. 2011 Oct 4;183(14):E1073-84. Epub 2011 Aug 29.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21876027 [PubMed - in process] Free Article Last word on ACE inhibitors/AT1R blockers and cancer: they can be protective, after all! &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;4.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;High Molecular Weight Coffee Melanoidins are Inhibitors for Matrix Metalloproteases.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Demarco LM, Fischer S, Henle T.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Agric Food Chem. 2011 Oct 1. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21961901 [PubMed - as supplied by publisher]Coffee, sir?  Melanoidins from coffee - a new group of MMP inhibitors that can play a pivotal role in cancer treatment.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;" />
<link rel="canonical" href="http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html" />
<meta property="og:url" content="http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html" />
<meta property="og:site_name" content="Ciência médica" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2011-10-15T11:15:00-03:00" />
<script type="application/ld+json">
{"description":"This message contains My NCBI what’s new results from the National Center for BiotechnologySender’s message: Sent on Saturday, 2011 Oct 08Search angiotensin cancer &lt;div&gt;&lt;div&gt;&lt;table bgcolor=&quot;#CCCCCC&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot;&gt;PubMed Results&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;Items 1 - 4&lt;/div&gt;&lt;div&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;1.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Tanaka N, Miyajima A, Kosaka T, Miyazaki Y, Shirotake S, Shirakawa H, Kikuchi E, Oya M.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.399. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21970881 [PubMed - as supplied by publisher]How angiotensin II type 1 receptor blockers can overcome platinum resistance in cancer cells.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;2.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Statin prescriptions and breast cancer recurrence risk: a danish nationwide prospective cohort study.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. Epub 2011 Aug 2.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21813413 [PubMed - in process]Simvastatin users had less breast cancer recurrence - a Harvard Medical School Study&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;3.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Yoon C, Yang HS, Jeon I, Chang Y, Park SM.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;CMAJ. 2011 Oct 4;183(14):E1073-84. Epub 2011 Aug 29.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21876027 [PubMed - in process] Free Article Last word on ACE inhibitors/AT1R blockers and cancer: they can be protective, after all! &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;4.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;High Molecular Weight Coffee Melanoidins are Inhibitors for Matrix Metalloproteases.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Demarco LM, Fischer S, Henle T.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Agric Food Chem. 2011 Oct 1. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21961901 [PubMed - as supplied by publisher]Coffee, sir?  Melanoidins from coffee - a new group of MMP inhibitors that can play a pivotal role in cancer treatment.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;","author":{"@type":"Person","name":"Francisco H C Felix"},"@type":"BlogPosting","url":"http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html","headline":"What’s new for ‘angiotensin AND cancer’ in PubMed - coffee, statins, ACE inhibitors and more!","dateModified":"2011-10-15T11:15:00-03:00","datePublished":"2011-10-15T11:15:00-03:00","mainEntityOfPage":{"@type":"WebPage","@id":"http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html"},"@context":"http://schema.org"}</script>
<!-- End Jekyll SEO tag -->

  <head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <!-- Begin Jekyll SEO tag v2.5.0 -->
<title>What’s new for ‘angiotensin AND cancer’ in PubMed - coffee, statins, ACE inhibitors and more! | Ciência médica</title>
<meta name="generator" content="Jekyll v3.7.4" />
<meta property="og:title" content="What’s new for ‘angiotensin AND cancer’ in PubMed - coffee, statins, ACE inhibitors and more!" />
<meta name="author" content="Francisco H C Felix" />
<meta property="og:locale" content="en" />
<meta name="description" content="This message contains My NCBI what’s new results from the National Center for BiotechnologySender’s message: Sent on Saturday, 2011 Oct 08Search angiotensin cancer &lt;div&gt;&lt;div&gt;&lt;table bgcolor=&quot;#CCCCCC&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot;&gt;PubMed Results&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;Items 1 - 4&lt;/div&gt;&lt;div&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;1.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Tanaka N, Miyajima A, Kosaka T, Miyazaki Y, Shirotake S, Shirakawa H, Kikuchi E, Oya M.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.399. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21970881 [PubMed - as supplied by publisher]How angiotensin II type 1 receptor blockers can overcome platinum resistance in cancer cells.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;2.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Statin prescriptions and breast cancer recurrence risk: a danish nationwide prospective cohort study.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. Epub 2011 Aug 2.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21813413 [PubMed - in process]Simvastatin users had less breast cancer recurrence - a Harvard Medical School Study&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;3.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Yoon C, Yang HS, Jeon I, Chang Y, Park SM.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;CMAJ. 2011 Oct 4;183(14):E1073-84. Epub 2011 Aug 29.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21876027 [PubMed - in process] Free Article Last word on ACE inhibitors/AT1R blockers and cancer: they can be protective, after all! &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;4.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;High Molecular Weight Coffee Melanoidins are Inhibitors for Matrix Metalloproteases.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Demarco LM, Fischer S, Henle T.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Agric Food Chem. 2011 Oct 1. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21961901 [PubMed - as supplied by publisher]Coffee, sir?  Melanoidins from coffee - a new group of MMP inhibitors that can play a pivotal role in cancer treatment.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;" />
<meta property="og:description" content="This message contains My NCBI what’s new results from the National Center for BiotechnologySender’s message: Sent on Saturday, 2011 Oct 08Search angiotensin cancer &lt;div&gt;&lt;div&gt;&lt;table bgcolor=&quot;#CCCCCC&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot;&gt;PubMed Results&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;Items 1 - 4&lt;/div&gt;&lt;div&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;1.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Tanaka N, Miyajima A, Kosaka T, Miyazaki Y, Shirotake S, Shirakawa H, Kikuchi E, Oya M.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.399. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21970881 [PubMed - as supplied by publisher]How angiotensin II type 1 receptor blockers can overcome platinum resistance in cancer cells.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;2.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Statin prescriptions and breast cancer recurrence risk: a danish nationwide prospective cohort study.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. Epub 2011 Aug 2.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21813413 [PubMed - in process]Simvastatin users had less breast cancer recurrence - a Harvard Medical School Study&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;3.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Yoon C, Yang HS, Jeon I, Chang Y, Park SM.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;CMAJ. 2011 Oct 4;183(14):E1073-84. Epub 2011 Aug 29.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21876027 [PubMed - in process] Free Article Last word on ACE inhibitors/AT1R blockers and cancer: they can be protective, after all! &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;4.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;High Molecular Weight Coffee Melanoidins are Inhibitors for Matrix Metalloproteases.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Demarco LM, Fischer S, Henle T.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Agric Food Chem. 2011 Oct 1. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21961901 [PubMed - as supplied by publisher]Coffee, sir?  Melanoidins from coffee - a new group of MMP inhibitors that can play a pivotal role in cancer treatment.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;" />
<link rel="canonical" href="http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html" />
<meta property="og:url" content="http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html" />
<meta property="og:site_name" content="Ciência médica" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2011-10-15T11:15:00-03:00" />
<script type="application/ld+json">
{"description":"This message contains My NCBI what’s new results from the National Center for BiotechnologySender’s message: Sent on Saturday, 2011 Oct 08Search angiotensin cancer &lt;div&gt;&lt;div&gt;&lt;table bgcolor=&quot;#CCCCCC&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot;&gt;PubMed Results&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;Items 1 - 4&lt;/div&gt;&lt;div&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;1.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Tanaka N, Miyajima A, Kosaka T, Miyazaki Y, Shirotake S, Shirakawa H, Kikuchi E, Oya M.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.399. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21970881 [PubMed - as supplied by publisher]How angiotensin II type 1 receptor blockers can overcome platinum resistance in cancer cells.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;2.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Statin prescriptions and breast cancer recurrence risk: a danish nationwide prospective cohort study.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. Epub 2011 Aug 2.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21813413 [PubMed - in process]Simvastatin users had less breast cancer recurrence - a Harvard Medical School Study&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;3.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Yoon C, Yang HS, Jeon I, Chang Y, Park SM.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;CMAJ. 2011 Oct 4;183(14):E1073-84. Epub 2011 Aug 29.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21876027 [PubMed - in process] Free Article Last word on ACE inhibitors/AT1R blockers and cancer: they can be protective, after all! &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;5&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td nowrap=&quot;nowrap&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;4.&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;High Molecular Weight Coffee Melanoidins are Inhibitors for Matrix Metalloproteases.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;Demarco LM, Fischer S, Henle T.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;J Agric Food Chem. 2011 Oct 1. [Epub ahead of print]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;10&quot;&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot;&gt;PMID: 21961901 [PubMed - as supplied by publisher]Coffee, sir?  Melanoidins from coffee - a new group of MMP inhibitors that can play a pivotal role in cancer treatment.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;","author":{"@type":"Person","name":"Francisco H C Felix"},"@type":"BlogPosting","url":"http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html","headline":"What’s new for ‘angiotensin AND cancer’ in PubMed - coffee, statins, ACE inhibitors and more!","dateModified":"2011-10-15T11:15:00-03:00","datePublished":"2011-10-15T11:15:00-03:00","mainEntityOfPage":{"@type":"WebPage","@id":"http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html"},"@context":"http://schema.org"}</script>
<!-- End Jekyll SEO tag -->


  <!--
  -->
 <link rel="alternate" type="application/rss+xml" title="" href="/ciencia-medica">

  <title>What's new for 'angiotensin AND cancer' in PubMed - coffee, statins, ACE inhibitors and more!</title>
  <meta name="description" content="This message contains My NCBI what's new results from the National Center for BiotechnologySender's message:  Sent on Saturday, 2011 Oct 08Search angiotensin...">

  <!-- Google Fonts loaded here depending on setting in _data/options.yml true loads font, blank does not-->
  
    <link href='//fonts.googleapis.com/css?family=Lato:400,400italic' rel='stylesheet' type='text/css'>
  

  <!-- Load up MathJax script if needed ... specify in /_data/options.yml file-->
  
    <script type="text/javascript" src="//cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
  

  <link rel="stylesheet" type="text/css" href="/ciencia-medica/css/tufte.css">
  <!-- <link rel="stylesheet" type="text/css" href="/ciencia-medica/css/print.css" media="print"> -->

  <link rel="canonical" href="http://fhcflx.github.io/ciencia-medica/2011/10/15/whats-new-for-angiotensin-and-cancer-in.html">
  <link rel="icon"
        type="image/png"
        href="/assets/img/badge.png">

  <link rel="alternate" type="application/rss+xml" title="Ciência médica" href="http://fhcflx.github.io/ciencia-medica/feed.xml" />

  <link rel="apple-touch-icon" sizes="180x180" href="/ciencia-medica/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/ciencia-medica/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/ciencia-medica/favicon-16x16.png">
  <link rel="manifest" href="/ciencia-medica/site.webmanifest">
  <link rel="mask-icon" href="/ciencia-medica/safari-pinned-tab.svg" color="#5bbad5">
  <link rel="shortcut icon" href="/ciencia-medica/favicon.ico">
  <meta name="msapplication-TileColor" content="#da532c">
  <meta name="msapplication-config" content="/ciencia-medica/browserconfig.xml">
  <meta name="theme-color" content="#ffffff">

</head>

  <body>
    <!--- Hader and nav template site-wide -->
<header>
    <a class="site-title" href="/ciencia-medica/"></a>
    <nav class="group">
	<a href="/ciencia-medica/"><img class="badge" src="/ciencia-medica/assets/img/mybadge.png" alt="CH"></a>
        
	
		
		    
		      <a href="/ciencia-medica/index.html">Medical Science</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/all-posts/index.html">All</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/vascular/index.html">Vascular anomalies</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/cancer2/index.html">Cancer</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/markers/index.html">Tags</a>
		    
	    
  	
		
		    
		      <a href="/ciencia-medica/about/index.html">About</a>
		    
	    
  	
        <!--<div class="trigger">
            
            
               
               <a class="page-link" href="/ciencia-medica/index.html">Medical Science</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/all-posts/index.html">All</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/vascular/index.html">Vascular anomalies</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/cancer2/index.html">Cancer</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/markers/index.html">Tags</a>
               
            
               
               <a class="page-link" href="/ciencia-medica/about/index.html">About</a>
               
            
            </div>-->
  </nav>
<div class="wrapper" style="text-align: right; line-height: 2em">
  
  

  
  
</div>
</header>

    <article class="group">
      <h1>What's new for 'angiotensin AND cancer' in PubMed - coffee, statins, ACE inhibitors and more!</h1>
<p class="subtitle">

15
Outubro
  
2011</p>





<ul class="tags">
  
    <li><a href="/ciencia-medica/marcadores#Cancer" class="tag">Cancer</a></li>
  
</ul>

This message contains My NCBI what's new results from the National Center for Biotechnology<br /><b>Sender's message: </b> <br />Sent on Saturday, 2011 Oct 08<br />Search <b>angiotensin cancer</b> <br /><div><br /><div><table bgcolor="#CCCCCC"><tbody><tr><td align="center">PubMed Results</td></tr></tbody></table>Items 1 - 4</div><br /><div><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">1.</td><td valign="top"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21970881" ref="ordinalpos=1">Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Tanaka N,  Miyajima A,  Kosaka T,  Miyazaki Y,  Shirotake S,  Shirakawa H,  Kikuchi E,  Oya M.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="British journal of cancer">Br J Cancer</span>. 2011 Oct 4. doi: 10.1038/bjc.2011.399. [Epub ahead of print]</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21970881 [PubMed - as supplied by publisher]<br /><br /><b>How angiotensin II type 1 receptor blockers can overcome platinum resistance in cancer cells.</b></td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">2.</td><td valign="top"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21813413" ref="ordinalpos=2">Statin prescriptions and breast cancer recurrence risk: a danish nationwide prospective cohort study.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Ahern TP,  Pedersen L,  Tarp M,  Cronin-Fenton DP,  Garne JP,  Silliman RA,  Sørensen HT,  Lash TL.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="Journal of the National Cancer Institute">J Natl Cancer Inst</span>. 2011 Oct 5;103(19):1461-8. Epub 2011 Aug 2.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21813413 [PubMed - in process]<br /><br /><b>Simvastatin users had less breast cancer recurrence - a Harvard Medical School Study</b></td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">3.</td><td valign="top"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21876027" ref="ordinalpos=3">Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Yoon C,  Yang HS,  Jeon I,  Chang Y,  Park SM.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne">CMAJ</span>. 2011 Oct 4;183(14):E1073-84. Epub 2011 Aug 29.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21876027 [PubMed - in process]<span style="color: #985735; font-weight: bold;">   Free Article&nbsp;</span><br /><br /><span style="color: #985735; font-weight: bold;">Last word on ACE inhibitors/AT1R blockers and cancer: they can be protective, after all! </span></td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">4.</td><td valign="top"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21961901" ref="ordinalpos=4">High Molecular Weight Coffee Melanoidins are Inhibitors for Matrix Metalloproteases.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Demarco LM,  Fischer S,  Henle T.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="Journal of agricultural and food chemistry">J Agric Food Chem</span>. 2011 Oct 1. [Epub ahead of print]</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21961901 [PubMed - as supplied by publisher]<br /><br /><b>Coffee, sir?&nbsp; Melanoidins from coffee - a new group of MMP inhibitors that can play a pivotal role in cancer treatment.</b></td></tr></tbody></table></div></div>


<article style="max-width: 90%;">
  <div id="disqus_thread"></div>
  <script>
    /**
     *  RECOMMENDED CONFIGURATION VARIABLES: EDIT AND UNCOMMENT THE SECTION BELOW TO INSERT DYNAMIC VALUES FROM YOUR PLATFORM OR CMS.
     *  LEARN WHY DEFINING THESE VARIABLES IS IMPORTANT: https://disqus.com/admin/universalcode/#configuration-variables
     */
    /*
    var disqus_config = function () {
        this.page.url = PAGE_URL;  // Replace PAGE_URL with your page's canonical URL variable
        this.page.identifier = PAGE_IDENTIFIER; // Replace PAGE_IDENTIFIER with your page's unique identifier variable
    };
    */
      (function() {  // DON'T EDIT BELOW THIS LINE
          var d = document, s = d.createElement('script');
              s.src = '//pharmak-on.disqus.com/embed.js';

            s.setAttribute('data-timestamp', +new Date());
            (d.head || d.body).appendChild(s);
        })();
  </script>
  <noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript" rel="nofollow">comments powered by Disqus.</a></noscript>
</article>


    </article>
    <span class="print-footer">What's new for 'angiotensin AND cancer' in PubMed - coffee, statins, ACE inhibitors and more! - October 15, 2011 - fhcflx</span>
    <footer>
  <hr class="slender">
  <ul class="footer-links">
    <li><a href="mailto:fhcflx@outlook.com"><span class="icon-mail"></span></a></li>
    
      <li>
        <a href="//www.twitter.com/fhcflx"><span class="icon-twitter"></span></a>
      </li>
    
      <li>
        <a href="//plus.google.com/+FranciscoHCFelix"><span class="icon-googleplus"></span></a>
      </li>
    
      <li>
        <a href="//github.com/fhcflx/ciencia-medica"><span class="icon-github"></span></a>
      </li>
    
      <li>
        <a href="//www.flickr.com/photos/fhcflx"><span class="icon-flickr"></span></a>
      </li>
    
      <li>
        <a href=""><span class="icon-feed"></span></a>
      </li>
    
    <li><a href=https://travis-ci.org/fhcflx/ciencia-medica ><img alt='travis-ci build' src=https://img.shields.io/travis/fhcflx/ciencia-medica.svg?colorA=a00000&colorB=a00000></a></li>
  </ul>
<div class="credits">
<span>&copy; 2019 &nbsp;&nbsp;FHCFLX</span></br> <br>
<span>Este sítio foi criado com o <a href="//github.com/clayh53/tufte-jekyll">tema Tufte para Ciência médica </a> no <a href="//jekyllrb.com">Jekyll</a>.</span>
</div>
</footer>

  </body>
</html>
